Profile
Currently, Jeong-Woo Jo holds the position of President, Chief Executive Officer & Director at SK Biopharmaceuticals Co., Ltd. He is also on the board of Arvelle Therapeutics International GmbH.
Jeong-Woo Jo active positions
| Companies | Position | Start |
|---|---|---|
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Director/Board Member | 2018-12-31 |
SK Life Science, Inc.
SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Corporate Officer/Principal | 2022-12-31 |
Former positions of Jeong-Woo Jo
| Companies | Position | End |
|---|---|---|
| SK BIOPHARMACEUTICALS CO., LTD. | Chief Executive Officer | 2022-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of new drugs and antibiotics | Health Technology |
SK Life Science, Inc.
SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Commercial Services |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Health Technology |
- Stock Market
- Insiders
- Jeong-Woo Jo
















